Genetic and epigenetic basis of chronic lymphocytic leukemia

Current Opinion in Hematology

Volumn 20, Issue 4, 2013, Pages 362-368

  Martín Subero, José I ^a   López Otín, Carlos ^b   Campo, Elías ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b DEPARTAMENTO DE BIOQUÍMICA Y BIOLOGÍA MOLECULAR   (Spain)

Author keywords

Chronic lymphocytic leukemia; DNA methylation; Gene mutation; Next generation sequencing

Indexed keywords

MYELOID DIFFERENTIATION FACTOR 88; NOTCH1 RECEPTOR; PROTEIN KINASE ZAP 70; TOLL LIKE RECEPTOR 2;

B LYMPHOCYTE; CELL DIFFERENTIATION; CHRONIC LYMPHATIC LEUKEMIA; CLINICAL FEATURE; DISEASE COURSE; DNA DAMAGE; DNA METHYLATION; EPIGENETICS; EXOME; GENE CONTROL; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE MUTATION; GENETIC ASSOCIATION; GENETICS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; TRISOMY 12;

CELL TRANSFORMATION, NEOPLASTIC; DNA METHYLATION; EPIGENESIS, GENETIC; EPIGENOMICS; GENOME-WIDE ASSOCIATION STUDY; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL; MUTATION;

EID: 84880222541     PISSN: 10656251     EISSN: 15317048     Source Type: Journal    
DOI: 10.1097/MOH.0b013e32836235dc     Document Type: Review

References (55)

1. Zenz T, Mertens D, Kuppers R, et al. From pathogenesis to treatment of chronic lymphocytic leukaemia. Nat Rev Cancer 2010; 10:37-50. An excellent review of the genetic and molecular mechanisms involved in the pathogenesis of the disease and their clinical implications.
2. Gaidano G, Foa R, Dalla-Favera R. Molecular pathogenesis of chronic lymphocytic leukemia. J Clin Invest 2012; 122:3432-3438. An excellent review of the genetic and molecular mechanisms involved in the pathogenesis of the disease and their clinical implications.
3. Dohner H, Stilgenbauer S, Benner A, et al. Genomic aberrations and survival in chronic lymphocytic leukemia. N Engl J Med 2000; 343:1910-1916.
4. Baylin SB, Jones PA. A decade of exploring the cancer epigenome: biological and translational implications. Nat Rev Cancer 2011; 11:726-734.
5. Kanduri M, Cahill N, Goransson H, et al. Differential genome-wide array-based methylation profiles in prognostic subsets of chronic lymphocytic leukemia. Blood 2010; 115:296-305.
6. Meyerson M, Gabriel S, Getz G. Advances in understanding cancer genomes through second-generation sequencing. Nat Rev Genet 2010; 11:685-696.
7. Puente XS, Pinyol M, Quesada V, et al. Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia. Nature 2011; 475: 101-105. This is the first whole-genome sequence analysis of CLL, which identifies several recurrent mutations and reveals their functional and clinical impact highlighting the relevance of next-generation sequencing studies in understanding this disease
8. Fabbri G, Rasi S, Rossi D, et al. Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation. J Exp Med 2011; 208:1389-1401. This study offers the first comprehensive catalog of recurrent somatic mutations in CLL and discovers new mechanisms in the pathogenesis of the disease.
9. Quesada V, Conde L, Villamor N, et al. Exome sequencing identifies recurrent mutations of the splicing factor SF3B1 gene in chronic lymphocytic leukemia. Nat Genet 2011; 44:47-52.This study offers the first comprehensive catalog of recurrent somatic mutations in CLL and discovers new mechanisms in the pathogenesis of the disease
10. Wang L, Lawrence MS, Wan Y, et al. SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. N Engl J Med 2011; 365:2497-2506.
11. Tiacci E, Schiavoni G, Forconi F, et al. Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. Blood 2012; 119:192-195.
12. Morin RD, Mendez-Lago M, Mungall AJ, et al. Frequent mutation of histonemodifying genes in non-Hodgkin lymphoma. Nature 2011; 476:298-303.
13. Lohr JG, Stojanov P, Lawrence MS, et al. Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing. Proc Natl Acad Sci USA 2012; 109:3879-3884.
14. Zhang J, Grubor V, Love CL, et al. Genetic heterogeneity of diffuse large B-cell lymphoma. Proc Natl Acad Sci USA 2013; 110:1398-1403.
15. Pasqualucci L, Trifonov V, Fabbri G, et al. Analysis of the coding genome of diffuse large B-cell lymphoma. Nat Genet 2011; 43:830-837.
16. Schmitz R, Young RM, Ceribelli M, et al. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics. Nature 2012; 490:116-120.
17. Richter J, Schlesner M, Hoffmann S, et al. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing. Nat Genet 2012; 44:1316-1320.
18. Love C, Sun Z, Jima D, et al. The genetic landscape of mutations in Burkitt lymphoma. Nat Genet 2012; 44:1321-1325.
19. Chapman MA, Lawrence MS, Keats JJ, et al. Initial genome sequencing and analysis of multiple myeloma. Nature 2011; 471:467-472.
20. Chiorazzi N, Ferrarini M. Cellular origin(s) of chronic lymphocytic leukemia: cautionary notes and additional considerations and possibilities. Blood 2011; 117:1781-1791.
21. Klein U, Tu Y, Stolovitzky GA, et al. Gene expression profiling of B cell chronic lymphocytic leukemia reveals a homogeneous phenotype related to memory B cells. J Exp Med 2001; 194:1625-1638.
22. Kulis M, Heath S, Bibikova M, et al. Epigenomic analysis detects widespread gene-body DNA hypomethylation in chronic lymphocytic leukemia. Nat Genet 2012; 44:1236-1242. This is the first genome-wide methylome study in CLL including the whole-genome bisulfite sequencing of several subpopulations of normal B-lymphocytes and tumor samples. The study reveals the complex epigenetic reprogramming of the methylome profile in the development of CLL
23. Seifert M, Sellmann L, Bloehdorn J, et al. Cellular origin and pathophysiology of chronic lymphocytic leukemia. J Exp Med 2012; 209:2183- 2198. This elegant study identifies mature CD5(Ã) B and a previously unrecognized CD5(Ã)CD27(Ã) postgerminal center B cell as the cells of origin of CLL with unmutated and mutated IGHV, respectively
24. Kikushige Y, Ishikawa F, Miyamoto T, et al. Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia. Cancer Cell 2011; 20:246-259 This study presents intriguing observations, suggesting that hematopoietic stem cells may be already primed to develop clonal proliferation of mature B-cells with CLL features.
25. Quesada V, Ramsay AJ, Rodriguez D, et al. The genomic landscape of chronic lymphocytic leukemia. BMC Med 2013; 11:124.
26. Ramsay AJ, Rodriguez D, Villamor N, et al. Frequent somatic mutations in components of the RNA processing machinery in chronic lymphocytic leukemia. Leukemia 2012. [Epub ahead of print].
27. Nik-Zainal S, Alexandrov LB, Wedge DC, et al. Mutational processes molding the genomes of 21 breast cancers. Cell 2012; 149:979-993.
28. Nik-Zainal S, Van LP, Wedge DC, et al. The life history of 21 breast cancers. Cell 2012; 149:994-1007.
29. Pleasance ED, Stephens PJ, O'Meara S, et al. A small-cell lung cancer genome with complex signatures of tobacco exposure. Nature 2010; 463: 184-190.
30. Pei L, Choi JH, Liu J, et al. Genome-wide DNA methylation analysis reveals novel epigenetic changes in chronic lymphocytic leukemia. Epigenetics 2012; 7:567-578.
31. Cahill N, Bergh AC, Kanduri M, et al. 450K-array analysis of chronic lymphocytic leukemia cells reveals global DNA methylation to be relatively stable over time and similar in resting and proliferative compartments. Leukemia 2013; 27:150-158.
32. Rahmatpanah FB, Carstens S, Hooshmand SI, et al. Large-scale analysis of DNA methylation in chronic lymphocytic leukemia. Epigenomics 2009; 1: 39-61.
33. Baer C, Claus R, Frenzel LP, et al. Extensive promoter DNA hypermethylation and hypomethylation is associated with aberrant microRNA expression in chronic lymphocytic leukemia. Cancer Res 2012; 72:3775-3785.
34. Kanduri M, Marincevic M, Halldorsdottir AM, et al. Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profiles. Epigenetics 2012; 7:1435-1442.
35. Tong WG, Wierda WG, Lin E, et al. Genome-wide DNA methylation profiling of chronic lymphocytic leukemia allows identification of epigenetically repressed molecular pathways with clinical impact. Epigenetics 2010; 5:499-508.
36. Cahill N, Rosenquist R. Uncovering the DNA methylome in chronic lymphocytic leukemia. Epigenetics 2013; 8:138-148.
37. Fabris S, Bollati V, Agnelli L, et al. Biological and clinical relevance of quantitative global methylation of repetitive DNA sequences in chronic lymphocytic leukemia. Epigenetics 2011; 6:188-194.
38. Rossi D, Rasi S, Fabbri G, et al. Mutations of NOTCH1 are an independent predictor of survival in chronic lymphocytic leukemia. Blood 2012; 119:521-529.
39. Rossi D, Bruscaggin A, Spina V, et al. Mutations of the SF3B1 splicing factor in chronic lymphocytic leukemia: association with progression and fludarabine-refractoriness. Blood 2011; 118:6904-6908.
40. Villamor N, Conde L, Martinez-Trillos A, et al. NOTCH1 mutations identify a genetic subgroup of chronic lymphocytic leukemia patients with high risk of transformation and poor outcome. Leukemia 2013; 27:1100-1106.
41. Balatti V, Bottoni A, Palamarchuk A, et al. NOTCH1 mutations in CLL associated with trisomy Blood 2012; 119:329-331.
42. Del Giudice I, Rossi D, Chiaretti S, et al. NOTCH1 mutations in Ã12 chronic lymphocytic leukemia (CLL) confer an unfavorable prognosis, induce a distinctive transcriptional profiling and refine the intermediate prognosis of Ã12 CLL. Haematologica 2012; 97:437-441.
43. Lopez C, Delgado J, Costa D, et al. Different distribution of NOTCH1 mutations in chronic lymphocytic leukemia with isolated trisomy 12 or associated with other chromosomal alterations. Genes Chromosomes Cancer 2012; 51:881-889.
44. Rossi D, Rasi S, Spina V, et al. Different impact of NOTCH1 and SF3B1 mutations on the risk of chronic lymphocytic leukemia transformation to Richter syndrome. Br J Haematol 2012; 158:426-429.
45. Oscier DG, Rose-Zerilli MJ, Winkelmann N, et al. The clinical significance of NOTCH1 and SF3B1 mutations in the UK LRF CLL4 trial. Blood 2013; 121:468-475
46. Shedden K, Li Y, Ouillette P, et al. Characteristics of chronic lymphocytic leukemia with somatically acquired mutations in NOTCH1 exon. Leukemia 2012; 26:1108-1110.
47. Rossi D, Fangazio M, Rasi S, et al. Disruption of BIRC3 associates with fludarabine chemorefractoriness in TP53 wild-type chronic lymphocytic leukemia. Blood 2012; 119:2854-2862. Identification of BIRC3 as a recurrent mutation in CLL associated with chemorefractoriness.
48. Ramsay AJ, Quesada V, Foronda M, et al. POT1 mutations cause telomere dysfunction in chronic lymphocytic leukemia. Nat Genet 2013; 45:526-530. Functional characterization of POT1 mutations, the first gene of the shelterin complex identified mutated in cancer. The mutations found in CLL cause telomere fragility.
49. Rodriguez D, Ramsay AJ, Quesada V, et al. Functional analysis of sucraseisomaltase mutations from chronic lymphocytic leukemia patients. Hum Mol Genet 2013.
50. Tili E, Michaille JJ, Luo Z, et al. The down-regulation of miR-125b in chronic lymphocytic leukemias leads to metabolic adaptation of cells to a transformed state. Blood 2012; 120:2631-2638.
51. Claus R, Lucas DM, Stilgenbauer S, et al. Quantitative DNA methylation analysis identifies a single CpG dinucleotide important for ZAP-70 expression and predictive of prognosis in chronic lymphocytic leukemia. J Clin Oncol 2012; 30:2483-2491.
52. Irving L, Mainou-Fowler T, Parker A, et al. Methylation markers identify high risk patients in IGHV mutated chronic lymphocytic leukemia. Epigenetics 2011; 6:300-306.
53. Bonnal S, Vigevani L, Valcarcel J. The spliceosome as a target of novel antitumour drugs. Nat Rev Drug Discov 2012; 11:847-859.
54. Lapalombella R, Sun Q, Williams K, et al. Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia. Blood 2012; 120:4621-4634.
55. Puente XS, Lopez-Otin C. The evolutionary biography of chronic lymphocytic leukemia. Nat Genet 2013; 45:229-231.